Published in Urol Int on January 04, 2012
Getting out of a tight spot: an overview of ureteroenteric anastomotic strictures. Nat Rev Urol (2016) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
The ileal neobladder: complications and functional results in 363 patients after 11 years of followup. J Urol (1999) 1.69
Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am (1992) 1.31
A comparison of the Bricker versus Wallace ureteroileal anastomosis in patients undergoing urinary diversion for bladder cancer. J Urol (2007) 1.27
Ureteral anastomosis in the orthotopic ileal neobladder: comparison of 2 techniques. J Urol (1997) 1.11
Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol (1994) 1.05
Stented versus nonstented ureteroileal anastomoses: is there a difference with regard to leak and stricture? J Urol (1985) 0.91
Primary endoscopic management versus open revision of ureteroenteric anastomotic strictures after urinary diversion--single institution contemporary series. J Endourol (2009) 0.84
Evaluation of direct versus non-refluxing technique and functional results in orthotopic Y-ileal neobladder after 12 years of follow up. Int J Urol (2007) 0.82
Persistent candiduria complicating intraureteral stenting: a case report and review of literature. W V Med J (2003) 0.82
Long-term results of endoureterotomy and open surgical revision for the management of ureteroenteric strictures after urinary diversion. J Urol (2003) 0.81
Long-term results of antegrade endoureterotomy using the holmium laser in patients with ureterointestinal strictures. Urology (2001) 0.80
Stented versus nonstented transverse colon conduits: a comparative report. Gynecol Oncol (1987) 0.80
Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med (2005) 17.61
Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int (2012) 2.88
Increased intra-abdominal fat predicts perioperative complications following minimally invasive partial nephrectomy. Urology (2013) 2.70
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol (2006) 2.51
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer (2014) 2.48
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood (2007) 2.30
Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology (2010) 2.27
Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A (2005) 2.25
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int (2007) 2.25
Comparative analysis of minimally invasive partial nephrectomy techniques in the treatment of localized renal tumors. Urology (2012) 2.22
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol (2012) 2.19
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol (2005) 2.13
Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur Urol (2007) 2.11
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy. Urology (2013) 2.11
Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology (2009) 2.10
Corporal "snake" maneuver: corporoglanular shunt surgical modification for ischemic priapism. J Sex Med (2009) 2.07
A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients. Urology (2009) 2.06
Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center. Urology (2011) 2.04
Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size? Urology (2012) 2.03
Primary carcinoid tumors of the kidney. J Urol (2006) 1.86
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol (2006) 1.86
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol (2006) 1.82
Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater. Urology (2011) 1.80
Priapism: pathogenesis, epidemiology, and management. J Sex Med (2010) 1.79
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76
Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. J Urol (2010) 1.74
Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology (2011) 1.70
Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome. J Urol (2004) 1.70
Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases. Mod Pathol (2007) 1.67
The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int (2007) 1.65
Laparoscopic pyeloplasty: current status. BJU Int (2005) 1.64
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann Surg (2004) 1.63
A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol Biol Phys (2012) 1.61
Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology (2007) 1.60
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol (2006) 1.60
Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol (2007) 1.56
Initial experience with laparoscopic transvesical ureteral reimplantation at the Children's Hospital of Philadelphia. J Urol (2006) 1.55
Corporal Burnett "Snake" surgical maneuver for the treatment of ischemic priapism: long-term followup. J Urol (2012) 1.54
Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (2011) 1.54
Complications of 2,775 urological laparoscopic procedures: 1993 to 2005. J Urol (2007) 1.53
Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun (2002) 1.53
Gene therapy for erectile dysfunction: fact or fiction? Eur Urol (2006) 1.51
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology (2008) 1.50
Long-term survival analysis after laparoscopic radical nephrectomy. J Urol (2005) 1.50
Comparison of perioperative outcomes of robot-assisted partial nephrectomy and open partial nephrectomy in patients with a solitary kidney. J Endourol (2014) 1.50
Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy. BJU Int (2009) 1.49
Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer. BJU Int (2013) 1.48
Do fibrin sealants impact negative outcomes after robot-assisted partial nephrectomy? J Endourol (2013) 1.48
Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology (2013) 1.47
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience. Prostate (2013) 1.46
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer. BJU Int (2012) 1.44
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther (2006) 1.44
Laparoscopic partial nephrectomy: effect of warm ischemia on serum creatinine. J Urol (2004) 1.44
Vena caval transection during retroperitoneoscopic nephrectomy: report of the complication and review of the literature. J Urol (2004) 1.43
Familial aggregation of urothelial cell carcinoma. Int J Cancer (2002) 1.43
Laparoscopic-assisted nephroureterectomy after radical cystectomy for transitional cell carcinoma. Int Braz J Urol (2007) 1.42
Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management. Ann Surg Oncol (2014) 1.42
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience. BJU Int (2013) 1.42
Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol (2012) 1.42
Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int (2008) 1.41
Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. J Urol (2006) 1.40
Penile ischemic injury in the exstrophy/epispadias spectrum: new insights and possible mechanisms. J Pediatr Urol (2010) 1.39
Laparoscopic management of ureteropelvic junction obstruction in patients with upper urinary tract anomalies. J Urol (2004) 1.39
Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis. J Sex Med (2012) 1.38
Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl (2003) 1.37
Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery. Eur Urol (2012) 1.37
Lymphangiography with sclerotherapy: a novel therapy for refractory chylous ascites. Can J Urol (2012) 1.37
Priapism: current principles and practice. Urol Clin North Am (2007) 1.36
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology (2006) 1.27
Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. Eur Urol (2012) 1.27
Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system. Urology (2012) 1.26
Laparoscopic pyeloplasty with concomitant pyelolithotomy. J Urol (2002) 1.23
Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol (2006) 1.21
Segregation analysis of urothelial cell carcinoma. Eur J Cancer (2006) 1.21
Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction. FASEB J (2006) 1.19
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy. BJU Int (2009) 1.18
Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol (2005) 1.17
Pancreatic injuries during laparoscopic urologic surgery. Urology (2004) 1.16
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int (2010) 1.15
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res (2010) 1.15
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med (2004) 1.14
Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol (2008) 1.14
Vascular pseudoaneurysms in urology: clinical characteristics and management. J Endourol (2010) 1.14
A case of florid cystitis glandularis. Nat Clin Pract Urol (2007) 1.12
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol (2012) 1.12
Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proc Natl Acad Sci U S A (2002) 1.11
Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology (2002) 1.10
Carcinosarcoma of the prostate with urothelial and squamous components. J Urol (2005) 1.09
Is telesurgery a new reality? Our experience with laparoscopic and percutaneous procedures. J Endourol (2003) 1.08
Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy. Urology (2007) 1.07
Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int (2013) 1.06
Priapism: new concepts in medical and surgical management. Urol Clin North Am (2011) 1.06
Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol (2005) 1.05